E. Falleti

发表

Endotoxin priming exacerbates acute reflux pancreatitis in the rat

C. Beltrami, M. Pirisi, A. Cavarape, 1996, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Procalcitonin: a marker of severity of acute pyelonephritis among children.

A. Tenore, E. Falleti, F. Valent, 2004, Pediatrics.

PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence

M. Pirisi, C. Fabris, E. Falleti, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Circulating levels of interleukin 10 and other cytokines in rheumatoid arthritis treated with cyclosporin A or combination therapy.

F. Salaffi, E. Falleti, S. De Vita, 1998, The Journal of rheumatology.

Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma.

M. Pirisi, C. Fabris, E. Falleti, 1996, Cancer investigation.

Increased Serum Lipoprotein(a) Levels in Patients with Early Renal Failure

C. Catena, E. Dell’Anna, E. Falleti, 1999, Annals of Internal Medicine.

Hyperglycemia-Induced Thrombin Formation in Diabetes: The Possible Role of Oxidative Stress

M. Pirisi, E. Falleti, E. Bartoli, 1995, Diabetes.

Physical training effects in renal transplant recipients

E. Falleti, G. Ferraccioli, G. Ferraccioli, 2010, Clinical transplantation.

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience

C. Fabris, E. Falleti, S. Cmet, 2022, Indian Journal of Gastroenterology.

IgM antibody response to the hepatitis C virus core protein in intravenous drug users.

M. Pirisi, C. Fabris, E. Falleti, 1999, Diagnostic microbiology and infectious disease.

PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease

Y. Kuo, H. Nischalke, A. Singal, 2015, The American Journal of Gastroenterology.

Effect of eating on plasma radical-trapping antioxidant activity (TRAP) in patients with cirrhosis.

M. Pirisi, C. Fabris, E. Falleti, 1999, Clinical Biochemistry.

Total Radical-Trapping Antioxidant Parameter in NIDDM Patients

E. Falleti, E. Bartoli, A. Ceriello, 1997, Diabetes Care.

Fibrinogen Plasma Levels as a Marker of Thrombin Activation in Diabetes

E. Falleti, F. Gonano, E. Bartoli, 1994, Diabetes.

Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis

M. Pirisi, C. Fabris, E. Falleti, 2005, Journal of Cancer Research and Clinical Oncology.

Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C.

M. Pirisi, C. Fabris, E. Falleti, 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Reactivity to B cell epitopes within hepatitis C virus core protein and hepatocellular carcinoma.

M. Pirisi, C. Fabris, E. Falleti, 1995, Cancer research.

Increase of Serum α1-Acid Glycoprotein Despite the Decline of Liver Synthetic Function in Cirrhotics with Hepatocellular Carcinoma

M. Pirisi, C. Fabris, E. Falleti, 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients.

E. Falleti, F. Gonano, E. Bartoli, 1997, Journal of the American Society of Nephrology : JASN.

Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.

E. Falleti, F. Gonano, E. Bartoli, 1996, Journal of the American Society of Nephrology : JASN.

A Comparison of Four Serum Markers of Fibrosis in the Diagnosis of Cirrhosis

M. Pirisi, C. Fabris, E. Falleti, 1997, Annals of clinical biochemistry.

Fibrinogen Plasma Levels as a Marker of Thrombin Activation: New Insights on the Role of Fibrinogen as a Cardiovascular Risk Factor

M. Pirisi, E. Falleti, F. Gonano, 1994, Thrombosis and Haemostasis.

Vitamin D and the risk of acute allograft rejection following human liver transplantation

M. Pirisi, C. Fabris, E. Falleti, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress.

E. Falleti, F. Gonano, E. Bartoli, 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Gene polymorphism at the interleukin 6 -174 G > C locus affects the outcome of chronic hepatitis B.

G. Fattovich, M. Pirisi, C. Fabris, 2009, The Journal of infection.

Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood

A. Tenore, E. Falleti, F. Valent, 2007, Scandinavian journal of infectious diseases.

D. Pinato, M. Pirisi, C. Fabris, 2010, Inflammation.

Blood lipids of patients with chronic hepatitis: differences related to viral etiology.

M. Pirisi, C. Fabris, E. Falleti, 1997, Clinica chimica acta; international journal of clinical chemistry.

Vitamin D deficiency and HCV chronic infection: what comes first?

C. Fabris, E. Falleti, D. Bitetto, 2011, Journal of hepatology.

Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

Gianluca Bontempi, D. Franchimont, H. Nischalke, 2014, Hepatology.

602 PNPLA3 RS734809 C/G POLYMORPHISM IN LIVER CIRRHOSIS: RELATIONSHIP WITH THE ETIOLOGY OF LIVER DISEASE AND HCC OCCURRENCE

M. Pirisi, C. Fabris, E. Falleti, 2011 .

Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation

M. Pirisi, C. Fabris, E. Falleti, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Evidence for a multifactorial control of serum erythropoietin concentration in liver disease.

M. Pirisi, C. Fabris, E. Falleti, 1993, Clinica chimica acta; international journal of clinical chemistry.

Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases.

M. Pirisi, C. Fabris, E. Falleti, 1996, Disease markers.

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis.

C. Fabris, E. Falleti, S. Cmet, 2020, Journal of clinical and experimental hepatology.

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.

R. Fanin, E. Falleti, E. Calistri, 2006, Experimental hematology.

Circulating standard CD44 isoform in patients with liver disease: relationship with other soluble adhesion molecules and evaluation of diagnostic usefulness.

M. Pirisi, C. Fabris, E. Falleti, 1997, Clinical biochemistry.

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia

D. Rossi, G. Gaidano, M. Pirisi, 2009, Leukemia & lymphoma.

Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules.

M. Pirisi, C. Fabris, E. Falleti, 1995, Clinica chimica acta; international journal of clinical chemistry.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2012, Hepatology.

85 INTERACTION BETWEEN CYCLOSPORINE AND RECIPIENT IL-28B RS12979860 C>T GENETIC POLYMORPHISMS IN THE ACHIEVEMENT OF SUSTAINED VIRAL RESPONSE FOR RECURRENT HEPATITIS C

A. Gasbarrini, F. Ponziani, C. Rigamonti, 2012 .

OC-24 Interaction between cyclosporine and recipient IL-28B rs12979860 C>T genetic polymorphisms in the achievement of sustained viral response for recurrent hepatitis C

A. Gasbarrini, F. Ponziani, C. Rigamonti, 2012 .

Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C.

M. Pirisi, C. Fabris, E. Falleti, 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome

P. Berloco, E. Falleti, M. Merli, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users.

F. Baralle, M. Pirisi, C. Fabris, 1998, Journal of clinical epidemiology.

Circulating intercellular adhesion molecule 1 predicts non-specific elevation of α1-fetoprotein

M. Pirisi, C. Fabris, E. Falleti, 2005, Journal of Cancer Research and Clinical Oncology.

Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass.

M. Pirisi, C. Fabris, E. Falleti, 1994, American journal of clinical pathology.

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis.

M. Pirisi, C. Fabris, E. Falleti, 2010, World journal of gastroenterology.

Endotoxin priming and liver damage by experimental duodenal obstruction in the rat

C. Beltrami, M. Pirisi, A. Cavarape, 2000, Pathology international.

Discordant results from hepatitis C virus genotyping by procedures based on amplification of different genomic regions

F. Baralle, M. Pirisi, C. Fabris, 1996, Journal of clinical microbiology.

IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.

M. Pirisi, C. Fabris, E. Falleti, 2011, Journal of hepatology.

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2013, PloS one.

Complementary role of vitamin D deficiency and the interleukin‐28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2011, Hepatology.

Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B

G. Fattovich, M. Pirisi, C. Fabris, 2010, Journal of medical virology.

Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.

F. Kronenberg, L. Sechi, C. Catena, 1997, JAMA.

Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome

C. Avellini, M. Pirisi, C. Fabris, 2011, Journal of Gastroenterology.

TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.

C. Avellini, M. Pirisi, C. Fabris, 2008, Cytokine.

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.

C. Fabris, E. Falleti, M. Bulajic, 2014, International journal of surgery.

Recipient Interleukin-28B Rs12979860 C/T Polymorphism and Acute Cellular Rejection After Liver Transplantation: Role of the Calcineurin Inhibitor Used

C. Avellini, M. Pirisi, C. Fabris, 2012, Transplantation.

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis.

C. Fabris, E. Falleti, S. Cmet, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon‐based antiviral therapy

G. Fattovich, M. Pirisi, C. Fabris, 2013, Hepatology.

Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress.

A. Cavarape, E. Falleti, F. Gonano, 1996, Metabolism: clinical and experimental.

Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2010, Immunogenetics.

Relationship among hepatic inflammatory changes, circulating levels of cytokines, and response to IFN-alpha in chronic hepatitis C.

M. Pirisi, C. Fabris, E. Falleti, 1998, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2007, Liver international : official journal of the International Association for the Study of the Liver.

Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease

D. Pinato, M. Pirisi, C. Fabris, 2009, Oncology.

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience

C. Fabris, E. Falleti, S. Cmet, 2022, Indian Journal of Gastroenterology.

Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis

P. Angeli, C. Fabris, E. Falleti, 2019, European journal of gastroenterology & hepatology.

Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients

C. Fabris, E. Falleti, M. Fabris, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Increased soluble ICAM-1 concentration and impaired delayed-type hypersensitivity skin tests in patients with chronic liver disease.

M. Pirisi, C. Fabris, E. Falleti, 1997, Journal of clinical pathology.

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

C. Fabris, E. Falleti, A. Sartor, 2022, Journal of Hepatology.

Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype

M. Pirisi, C. Fabris, E. Falleti, 2011, Journal of Clinical Immunology.

Will Vitamin D Supplementation Have a Role in the Treatment of Patients with Chronic Hepatitis C

G. Fattovich, C. Fabris, E. Falleti, 2012 .

MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.

C. Avellini, M. Pirisi, C. Fabris, 2009, Alcoholism, clinical and experimental research.

Sod and GSH Inhibit the High Glucose-Induced Oxidative Damage and the PDGF Increased Secretion in Cultured Human Endothelial Cells

E. Falleti, A. Ceriello, P. Russo, 1995, Thrombosis and Haemostasis.

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

C. Rigamonti, C. Fabris, E. Falleti, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

M. Pirisi, C. Fabris, E. Falleti, 2011, Journal of gastroenterology and hepatology.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation

C. Avellini, M. Pirisi, C. Fabris, 2007, Journal of gastroenterology and hepatology.

Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of AST to the platelet ratio index.

M. Pirisi, C. Fabris, E. Falleti, 2006, Clinical biochemistry.

Serum iron indices as a measure of iron deposits in chronic hepatitis C.

C. Avellini, M. Pirisi, C. Fabris, 2001, Clinica chimica acta; international journal of clinical chemistry.

Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2008, Clinical Chemistry and Laboratory Medicine.

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients

E. Falleti, M. Fabris, S. Cmet, 2023, Vaccines.

Endogenous Interferon-α Concentration and Outcome of Interferon Treatment in Patients with Chronic Hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 1997, Digestive Diseases and Sciences.

Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C.

M. Pirisi, C. Fabris, E. Falleti, 2010, Human immunology.

Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C.

M. Pirisi, C. Fabris, E. Falleti, 2012, Cytokine.

Influence of angiotensin‐converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C

M. Pirisi, C. Fabris, E. Falleti, 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver‐transplanted patients

C. Avellini, M. Pirisi, C. Fabris, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases

M. Pirisi, C. Fabris, E. Falleti, 2012, Journal of medical virology.

1155 IINTERLEUKIN 28B RS12979860 C/T POLYMORPHISM AND SERUM CHOLESTEROL AS PREDICTORS OF FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES

M. Pirisi, C. Fabris, E. Falleti, 2011 .

Bone marrow B-cell clonal expansion in type II mixed cryoglobulinaemia: association with nephritis.

C. Beltrami, M. Isola, E. Falleti, 2007, Rheumatology.

Prediction of serum markers of fibrosis by levels of circulating intercellular adhesion molecule-1 in acute and chronic liver disease.

M. Pirisi, C. Fabris, E. Falleti, 1994, Clinical biochemistry.

Usefulness of acoustic radiation force impulse and fibrotest in liver fibrosis assessment after liver transplant.

C. Fabris, E. Falleti, S. Cmet, 2016, Annals of hepatology.

Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C.

M. Pirisi, C. Fabris, E. Falleti, 2009 .

Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection

G. Fattovich, M. Pirisi, C. Fabris, 2012, Clinical and experimental immunology.

Toll Like Receptor 4 D299G Associates with Disease Progression in Caucasian Patients with Chronic HBV Infection: Relationship with Gender

G. Fattovich, C. Fabris, E. Falleti, 2013, Journal of Clinical Immunology.

Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.

F. Kronenberg, C. Catena, G. Utermann, 1997, JAMA.

Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience

C. di Loreto, E. Falleti, S. Cmet, 2023, Journal of clinical medicine.

Vitamin D and the risk of acute allograft rejection following human liver transplantation

M. Pirisi, C. Fabris, E. Falleti, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Physical training effects in renal transplant recipients

E. Falleti, G. Ferraccioli, D. Montanaro, 2010, Clinical transplantation.